Victory Capital Management Inc Lannett CO Inc Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$5.75 - $7.13 $319,740 - $396,477	-55,607 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$4.9 - $7.12 $91,370 - $132,766	-18,647 Reduced 25.11%	55,607 $340,000
Q2 2020 Aug 07, 2020	BUY	$6.43 - $9.86 $252,872 - $387,764	39,327 Added 112.6%	74,254 $539,000
Q1 2020 May 04, 2020	BUY	$6.36 - $10.05 $145,764 - $230,335	22,919 Added 190.86%	34,927 $243,000
Q4 2019 Feb 06, 2020	SELL	$8.49 - $12.81 $41,286 - $62,295	-4,863 Reduced 28.82%	12,008 $106,000
Q4 2019 Feb 04, 2020	BUY	$8.49 - $12.81 $108,366 - $163,506	12,764 Added 310.79%	16,871 $137,000
Q3 2019 Nov 12, 2019	BUY	$5.58 - $14.47 $22,917 - $59,428	4,107 New	4,107 $46,000
Q3 2018 Nov 01, 2018	SELL	$4.75 - $14.5 $47,780 - $145,855	-10,059 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$13.3 - $17.45 $18,380 - $24,115	1,382 Added 15.93%	10,059 $137,000
Q1 2018 May 04, 2018	BUY	$14.7 - $24.95 $127,551 - $216,491	8,677 New	8,677 $139,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.